Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Free Cash Flow
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
|
Free Cash Flow
¥12.4m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-28%
|
|
|
I
|
Inner Mongolia BaoTou Steel Union Co Ltd
SSE:600010
|
Free Cash Flow
¥548.7m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Baoshan Iron & Steel Co Ltd
SSE:600019
|
Free Cash Flow
¥23.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
W
|
Western Superconducting Technologies Co Ltd
SSE:688122
|
Free Cash Flow
-¥115.9m
|
CAGR 3-Years
33%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
C
|
CITIC Pacific Special Steel Group Co Ltd
SZSE:000708
|
Free Cash Flow
¥13.9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Inner Mongolia Dazhong Mining Co Ltd
SZSE:001203
|
Free Cash Flow
¥321.8m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Glance View
Xinjiang Baihuacun Pharam Tech Co., Ltd. provides medical research and development services as a contract research organization (CRO). The company is headquartered in Urumqi, Xinjiang and currently employs 722 full-time employees. The firm's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The firm is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The firm is also engaged in leasing and property services. The firm mainly conducts business within the domestic market.
See Also
What is Xinjiang Bai Hua Cun Pharma Tech Co Ltd's Free Cash Flow?
Free Cash Flow
12.4m
CNY
Based on the financial report for Dec 31, 2025, Xinjiang Bai Hua Cun Pharma Tech Co Ltd's Free Cash Flow amounts to 12.4m CNY.
What is Xinjiang Bai Hua Cun Pharma Tech Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-28%
Over the last year, the Free Cash Flow growth was -78%. The average annual Free Cash Flow growth rates for Xinjiang Bai Hua Cun Pharma Tech Co Ltd have been -37% over the past three years , and -28% over the past ten years .
